Literature DB >> 10661843

Differentiated thyroid cancer in children and adolescents: the importance of adequate surgery and review of literature.

U Hallwirth1, J Flores, K Kaserer, B Niederle.   

Abstract

Within 25 years, 13 girls and 5 boys between the ages of 9 to 20 years were treated for differentiated thyroid cancer (DTC) at our institution. In 67% of the cases the diagnosis was made at an advanced stage indicated by cervical lymphnode metastases, two children showed metastases of the lung. Except for one girl, all patients underwent a total thyroidectomy with various forms of lymph node dissections. All were treated post-surgically with radio-iodine (131I) and all patients received levothyroxine in suppressive doses. The complication rate was low (laryngeal nerve injury in only 3 cases and no permanent hypoparathyroidism) and after a follow-up period of 26 years all patients are alive and without disease. In the case of DTC in children and adolescents, a total thyroidectomy with an appropriate lymph node dissection is the best surgical management. Besides the rather high incidence of local and distant recurrence, particularly in this age group, the detection and treatment of the metastases with radio-iodine are significantly facilitated by this surgical procedure. Additionally it allows the use of serum thyroglobulin as a reliable indicator of recurrence. To prevent high complication rates, surgical treatment should be performed in centers with skilled and experienced endocrine surgeons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10661843     DOI: 10.1055/s-2008-1072283

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  6 in total

1.  2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer.

Authors:  R Elisei; M Alevizaki; B Conte-Devolx; K Frank-Raue; V Leite; G R Williams
Journal:  Eur Thyroid J       Date:  2012-12-19

2.  Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer.

Authors:  Francoise Borson-Chazot; Sylvain Causeret; Jean-Christophe Lifante; Marylin Augros; Nicole Berger; Jean-Louis Peix
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

3.  Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008.

Authors:  Ian D Hay; Tomas Gonzalez-Losada; Megan S Reinalda; Jennifer A Honetschlager; Melanie L Richards; Geoffrey B Thompson
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

4.  Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.

Authors:  Yuri E Demidchik; Eugene P Demidchik; Christoph Reiners; Johannes Biko; Mariko Mine; Vladimir A Saenko; Shunichi Yamashita
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

5.  Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the yonsei university health system.

Authors:  Seulkee Park; Jun Soo Jeong; Haeng Rang Ryu; Cho-Rok Lee; Jae Hyun Park; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

6.  Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival.

Authors:  Nobuyuki Wada; Kiminori Sugino; Takashi Mimura; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Keiko Ohkuwa; Hirotaka Nakayama; Shohei Hirakawa; Yasushi Rino; Munetaka Masuda; Koichi Ito
Journal:  BMC Cancer       Date:  2009-09-01       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.